Li-Li Liu1,2, Shi-Lu Chen1,2, Yu-Hua Huang1,2, Xia Yang1,2, Chun-Hua Wang1,2, Jie-Hua He1,2, Jing-Ping Yun1,2, Rong-Zhen Luo1,2. 1. Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine Guangzhou 510060, China. 2. Department of Pathology, Sun Yat-sen University Cancer Center Guangzhou 510060, China.
Abstract
BACKGROUND: Cancer metastasis is the major reason for cancer-related deaths, but the mechanism of cancer metastasis still unclear. Adrenomedullin (ADM), a peptide hormone, functions as a local paracrine and autocrine mediator with multiple biological activities, such as angiogenesis, cell proliferation, and anti-inflammation. However, the expression and potential function of ADM in triple-negative breast cancer (TNBC) remain unclear. METHODS: Real-time polymerase chain reaction and western blotting were performed to examine the expression of ADM in TNBC tissues and cell lines. A total of 458 TNBC tissue samples and adjacent nontumor tissue samples were detected by immunochemistry to determine the correlation between ADM expression and clinicopathological characteristics. We determined the role and mechanistic pathways of ADM in tumor metastasis in cell lines. RESULTS: Our data showed that ADM expression was noticeably decreased in TNBC samples and cell lines. Low expression levels correlate with an increased risk of recurrence and metastasis. Furthermore, low ADM expression was associated with poor prognosis and was an independent marker for TNBC. In vitro, ADM may decrease cancer cell invasion, which is likely the result of its effect on the cancer cell epithelial-mesenchymal transition. CONCLUSIONS: Our findings suggest that ADM is a valuable biomarker for TNBC prognosis and an anti-metastasis candidate therapeutic target in triple-negative breast cancer. AJTR
BACKGROUND:Cancer metastasis is the major reason for cancer-related deaths, but the mechanism of cancer metastasis still unclear. Adrenomedullin (ADM), a peptide hormone, functions as a local paracrine and autocrine mediator with multiple biological activities, such as angiogenesis, cell proliferation, and anti-inflammation. However, the expression and potential function of ADM in triple-negative breast cancer (TNBC) remain unclear. METHODS: Real-time polymerase chain reaction and western blotting were performed to examine the expression of ADM in TNBC tissues and cell lines. A total of 458 TNBC tissue samples and adjacent nontumor tissue samples were detected by immunochemistry to determine the correlation between ADM expression and clinicopathological characteristics. We determined the role and mechanistic pathways of ADM in tumor metastasis in cell lines. RESULTS: Our data showed that ADM expression was noticeably decreased in TNBC samples and cell lines. Low expression levels correlate with an increased risk of recurrence and metastasis. Furthermore, low ADM expression was associated with poor prognosis and was an independent marker for TNBC. In vitro, ADM may decrease cancer cell invasion, which is likely the result of its effect on the cancer cell epithelial-mesenchymal transition. CONCLUSIONS: Our findings suggest that ADM is a valuable biomarker for TNBC prognosis and an anti-metastasis candidate therapeutic target in triple-negative breast cancer. AJTR
Authors: J J Evans; K Chitcholtan; J M Dann; P Guilford; Gavin Harris; L K Lewis; J Nagase; A A W Welkamp; R Zwerus; P H Sykes Journal: Gynecol Oncol Date: 2011-12-16 Impact factor: 5.482
Authors: J Sakata; T Shimokubo; K Kitamura; S Nakamura; K Kangawa; H Matsuo; T Eto Journal: Biochem Biophys Res Commun Date: 1993-09-15 Impact factor: 3.575
Authors: Liangjing Wang; Manish Gala; Masayoshi Yamamoto; Maria S Pino; Hirotoshi Kikuchi; Daniel S Shue; Senji Shirasawa; Thomas R Austin; Maureen P Lynch; Bo R Rueda; Lawrence R Zukerberg; Daniel C Chung Journal: Int J Cancer Date: 2013-11-07 Impact factor: 7.396
Authors: Jacqueline Lammert; Maryam Basrai; Joachim Struck; Oliver Hartmann; Christoph Engel; Stephan C Bischoff; Anika Berling-Ernst; Martin Halle; Marion Kiechle; Sabine Grill Journal: Geburtshilfe Frauenheilkd Date: 2022-06-03 Impact factor: 2.754